Trademark: 79289697
Status Date
Tuesday, July 27, 2021
Registration Number
6430514
Registration Date
Tuesday, July 27, 2021
Filing Date
Wednesday, May 13, 2020
Published for Opposition
Tuesday, May 11, 2021
1 Reagents for research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use
5 Medical and veterinary preparations for therapeutic purposes, namely pharmaceutical and biopharmaceutical preparations for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; pharmaceutical and biopharmaceutical preparations for cell therapy; pharmaceutical and biopharmaceutical preparations for modifying human or animal cells for medical or therapeutic purposes; biological, chemical and biochemical reagents for medical use
9 Downloadable bioinformatics software for genomic data analysis; downloadable computer software platforms for genomic data analysis in the fields of ophthalmology, haematology, immunology, neurology, respiratory diseases, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; scientific apparatus for measuring and analysing scientific study data in the nature of apparatus for recording, transmission or reproduction of data including video, audio, images and text; data analysis apparatus in the nature of data processing equipment and computers and downloadable operating computer software sold as a unit; downloadable scientific data analysis software
40 Treatment and processing of biological materials, namely cells, stem cells, induced pluripotent stem cells; custom manufacture of therapeutic drugs, namely custom manufacture of transcription factors, cells and cell therapies, gene therapies ; information, advisory and consultancy services in relation to all of the aforesaid services
42 Scientific and technological services, namely, research and design in the fields of ophthalmology, haematology, immunology, neurology, respiratory diseases, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; industrial research services in the field of cell therapies and gene therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services; software as a service (SaaS) services featuring software for use in genomic data analysis; platform as a service (Paas) services that feature a computer bioinformatics platform for use in manufacturing therapeutics; providing a bioinformatics platform for identifying transcription factors to turn one cell type into another cell type; advisory and consultancy relating to all the aforesaid services
44 Medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; medical services in the nature of manipulation of human and animal cells for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies
Jan 4, 2022
Final Decision Transaction Processed By Ib
Dec 13, 2021
Final Disposition Notice Sent To Ib
Dec 13, 2021
Final Disposition Processed
Oct 27, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jul 27, 2021
Registered-Principal Register
May 11, 2021
Notification Processed By Ib
May 11, 2021
Official Gazette Publication Confirmation E-Mailed
May 11, 2021
Published For Opposition
Apr 21, 2021
Notification Of Possible Opposition Sent To Ib
Apr 21, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 21, 2021
Notification Of Notice Of Publication E-Mailed
Apr 2, 2021
Approved For Pub - Principal Register
Apr 2, 2021
Examiner's Amendment Entered
Apr 2, 2021
Notification Of Examiners Amendment E-Mailed
Apr 2, 2021
Examiners Amendment E-Mailed
Apr 2, 2021
Examiners Amendment -Written
Mar 25, 2021
Notification Of Final Refusal Emailed
Mar 25, 2021
Final Refusal E-Mailed
Mar 25, 2021
Final Refusal Written
Mar 4, 2021
Teas/Email Correspondence Entered
Mar 4, 2021
Correspondence Received In Law Office
Mar 4, 2021
Teas Response To Office Action Received
Oct 4, 2020
Refusal Processed By Ib
Sep 11, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Sep 11, 2020
Refusal Processed By Mpu
Aug 12, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Aug 11, 2020
Non-Final Action Written
Aug 10, 2020
Assigned To Examiner
Jul 25, 2020
Application Filing Receipt Mailed
Jul 21, 2020
New Application Office Supplied Data Entered In Tram
Jul 16, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
